Clinical trials
Terminated Phase 1/2 Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 62 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ESSA Pharmaceuticals | 2 |
| Medical University of South Carolina | 2 |
| NYU Langone Health | 2 |
| National Cancer Institute (NCI) | 2 |
| Barinthus Biotherapeutics | 1 |
| Beth Israel Medical Center | 1 |
| BioNTech SE | 1 |
| Bostwick Laboratories | 1 |
| Cell Genesys | 1 |
| Clarity Pharmaceuticals Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 62 |
| Breast Neoplasms | 6 |
| Neoplasm Metastasis | 6 |
| Ovarian Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Carcinoma, Transitional Cell | 2 |
| Endometrial Neoplasms | 2 |
| Genital Diseases, Male | 2 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.